Cargando…

Functional characterization of HIV-1 Nef proteins with heterologous membrane targeting signals

Detalles Bibliográficos
Autores principales:	Geist, Miriam M, Pan, Xiaoyu, Fackler, Oliver T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848020/ http://dx.doi.org/10.1186/1742-4690-10-S1-P36

Ejemplares similares

HIV-1 Nef compensates for disorganization of the Immunological Synapse by inducing TGN-associated Lck signaling
por: Pan, Xiaoyu, et al.
Publicado: (2011)

HIV-1 Nef targets calnexin: a novel mechanism behind Nef effects on host cell and viral proteins
por: Jennelle, Lucas, et al.
Publicado: (2013)

Nef interferes with development of thymic T cell precursors: differential mechanisms in HIV and SIV
por: Meuwissen, PJ, et al.
Publicado: (2011)

HIV-1 Nef: a multifaceted modulator of T cell receptor signaling
por: Abraham, Libin, et al.
Publicado: (2012)

Understanding the nature of the Nef requirement for HIV-1 infectivity
por: Rosa, Annachiara, et al.
Publicado: (2013)

HIV Nef- and Notch1-dependent Endocytosis of ADAM17 Induces Vesicular TNF Secretion in Chronic HIV Infection
por: Ostalecki, Christian, et al.
Publicado: (2016)

Comparative proteomics of wild-type and nef-deleted HIV-1 particles
por: Brégnard, Christelle, et al.
Publicado: (2011)

Impairment of viral replication capacity by nef alleles from HIV elite controllers
por: Mwimanzi, Philip, et al.
Publicado: (2011)

HIV-1 Nef alters podosomes and promotes the mesenchymal migration in human macrophages
por: Vérollet, Christel, et al.
Publicado: (2013)

Potential role of HIV-1 Nef and human M6B in HIV-associated neurological disorders
por: Moetter, Jessica, et al.
Publicado: (2010)

Molecular Design, Functional Characterization and Structural Basis of a Protein Inhibitor Against the HIV-1 Pathogenicity Factor Nef
por: Breuer, Sebastian, et al.
Publicado: (2011)

P09-10. Impact of CTL escape mutations in HIV-1 Nef on viral replication
por: Oniangue-Ndza, C, et al.
Publicado: (2009)

A Conserved GPG-Motif in the HIV-1 Nef Core Is Required for Principal Nef-Activities
por: Martínez-Bonet, Marta, et al.
Publicado: (2015)

CD4.CD8 ratio decrease in AIDS, explained by a molecular mimicry between African HIV-1 Nef and Notch-1. Nef as a target for vaccine and NF-Kb inhibitors (salicylate, resveratrol,curcumin, epigallocatechine-3-gallate)
por: Tran, Guy MK, et al.
Publicado: (2012)

Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor
por: Fackler, Oliver T.
Publicado: (2015)

Critical role of calnexin in Nef-mediated inactivation of ABCA1
por: Jennelle, Lucas, et al.
Publicado: (2011)

The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design
por: Zembe, L, et al.
Publicado: (2012)

P16-29. HIV Nef-specific T cells: Th1/CTL, Th2 and Th17 responses
por: Montes, M, et al.
Publicado: (2009)

P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes
por: Côrtes, FH, et al.
Publicado: (2009)

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda
por: Kyosiimire-Lugemwa, J, et al.
Publicado: (2009)

Naturally-arising amino acid polymorphisms of HIV-1 Nef that differentially modulate downregulation of HLA-A and HLA-B molecules
por: Mahiti, Macdonald, et al.
Publicado: (2013)

Changes of biological properties and pathogenesis of CAEV chimeras expressing Nef and Vpx/Vpr accessory proteins in infected goats
por: Jin, Yuhai, et al.
Publicado: (2009)

P03-04. Increased virulence of CAEV chimeras expressing Nef and Vpx/Vpr accessory proteins in infected goats
por: Jin, Y, et al.
Publicado: (2009)

P18-04. MVA-nef vaccination induces specific T-cell responses exerting functions associated with non-progressive disease in HIV-1 infected individuals
por: Kutscher, S, et al.
Publicado: (2009)

Association with PAK2 Enables Functional Interactions of Lentiviral Nef Proteins with the Exocyst Complex
por: Imle, Andrea, et al.
Publicado: (2015)

Chemotactic activity of HIV-1 Nef for human monocytes
por: Lehmann, MH, et al.
Publicado: (2006)

HIV-1 Nef Employs Two Distinct Mechanisms to Modulate Lck Subcellular Localization and TCR Induced Actin Remodeling
por: Haller, Claudia, et al.
Publicado: (2007)

Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
por: Banerjee, K, et al.
Publicado: (2012)

P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
por: Wild, J, et al.
Publicado: (2009)

P16-11. HLA-B57/5801 induces preferential CD27 expression on HIV-Gag but not Nef specific central memory CD8+T cells controlling HIV
por: Xie, J, et al.
Publicado: (2009)

Nef variants from non-pathogenic lentiviral strains inhibit iron uptake through an AP2-dependent inhibition of transferrin endocytosis
por: Koppensteiner, Herwig, et al.
Publicado: (2013)

Stimulation of antiviral cellular immune responses by therapeutic vaccination of HIV-1-infected patients with dendritic cells transfected with gag, tat, rev and nef mRNA
por: Van Gulck, Ellen, et al.
Publicado: (2011)

The enhancement of HIV-1 infectivity by Nef depends on dynamin 2
por: Pizzato, Massimo, et al.
Publicado: (2006)

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
por: Bauer, A, et al.
Publicado: (2012)

Heterologous neutralization breadth persists despite B-lymphocyte dysfunction in chronic HIV-1 infection
por: Murphy, MK, et al.
Publicado: (2012)

P17-12. Immunogenicity comparison of dna vaccines encompassing HIV-1 tat, rev, integrase (C-half), vif and nef genes derived from different clades
por: Wan, Y, et al.
Publicado: (2009)

Heterologous expression and purification of Leptospira spp recombinant proteins to leptospirosis vaccine development
por: Deliberalli, Ivânia, et al.
Publicado: (2014)

P19-47. Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
por: Gabitzsch, ES, et al.
Publicado: (2009)

Determinants in HIV-1 Nef for enhancement of virus replication and depletion of CD4(+ )T lymphocytes in human lymphoid tissue ex vivo
por: Homann, Stefanie, et al.
Publicado: (2009)

P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial
por: Fellay, J, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_74v49g53krocuh77cjcarg5ukd